Current Treatments in Marginal Zone Lymphoma
Cancer Network,
This review provides an updated analysis of the literature and discusses the authors' approach to the diagnosis and treatment…
Phase 2 Study Evaluating the Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)
Overview of attention for article published in Blood, November 2020
Altmetric Badge
About this Attention Score
-
Above-average Attention Score compared to outputs of the same age (64th percentile)
-
Above-average Attention Score compared to outputs of the same age and source (57th percentile)
Readers on
- mendeley
- 7 Mendeley